Existing investors Social Capital Partnership and Safeguard Scientifics also participated in this funding round.
Syapse has carved out a market-leading position in the clinical implementation of precision medicine for oncology and will use this funding round to drive the expansion of its software, the Syapse Precision Medicine Platform, in community health systems. The cloud-based software was built to enable four key processes:
- Integrating clinical, genomic and other molecular data from medical records, labs and pharmacies to see the full longitudinal profile of a patient
- Providing guidance on the appropriate diagnostic and therapeutic strategy, based on clinical best practices
- Implementing treatment decisions more effectively, and coordinating complex care across large, geographically dispersed care teams
- Rigorously measuring patient outcomes to rapidly learn what works and improve best practices
More articles on health IT:
A year of Allscripts: 6 biggest stories from 2015
MetroHealth System receives HIMSS Davies award
Marin General Hospital, Royal Philips enter $90M, 15-year partnership to use technology to transform care
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.